SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharmaceuticals files ANDA for cardiac drug to USFDA

26 Sep 2017 Evaluate

Vista Pharmaceuticals has submitted an Abbreviated New Drug Application (ANDA) to US Food and Drug Administration (USFDA) on September 25, 2017 for a cardiac drug. This project is partnered with an US based company.

Recently, the company’s formulation facility at APIIC Industrial Estate, Nalgonda District in state of Telangana, which was inspected by US Food & Drug Administration (USFDA) during September 2016, had received Establishment Inspection Report (EIR), thereby confirming the closure of the inspection.

Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.


Vista Pharma Share Price

7.19 0.00 (0.00%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1662.00
Dr. Reddys Lab 1212.00
Cipla 1225.30
Zydus Lifesciences 925.00
Lupin 2290.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×